The breast cancer drug Herceptin may now have a role in treating stomach cancer as well, according to study results announced here on Sunday at the annual meeting of the American Society of Clinical Oncology.
Scientists also announced that a new class of drugs called PARP inhibitors has shown promise against hard-to-treat forms of breast cancer and that a cancer vaccine for non-Hodgkin’s lymphoma that struck out twice might have succeeded on a third try. Link
No comments:
Post a Comment